Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
Get App Open
In App
Open App

LIVE COVERAGE AND VIDEO PARTNERS

Lenovo Tech Today India Prestige Group Acer India ENO

PARTNERS

Tata AIA Life Insurance
Hafele
Motilal Oswal
SMC Global Securities Limited
SBI Life
DSP Mutual Fund
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS & DRUGS > News - Eris Lifesciences

Eris Lifesciences

BSE: 540596|NSE: ERIS|ISIN: INE406M01024|SECTOR: Pharmaceuticals & Drugs
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 03, 16:01
622.50
-2.7 (-0.43%)
VOLUME 1,840
LIVE
NSE
Feb 03, 15:50
625.20
-0.35 (-0.06%)
VOLUME 26,438
News on Eris Lifesciences
Select Year: 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Eris Life Consolidated December 2022 Net Sales at Rs 423.26 crore, up 27.43% Y-o-Y

2.33 pm | 20 Jan 2023 |  Source: Moneycontrol.com

NULL...

Eris Life Standalone December 2022 Net Sales at Rs 332.01 crore, up 8.99% Y-o-Y

1.00 pm | 20 Jan 2023 |  Source: Moneycontrol.com

NULL...

Buy Eris Lifesciences; target of Rs 780: Motilal Oswal

6.07 pm | 18 Jan 2023 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Eris Lifesciences recommended buy rating on the stock with a target price of Rs 780 in its research report dated January 1...

Eris Lifesciences falls as margins contract; derma brands' acquisition fails to cheer Street

3.11 pm | 18 Jan 2023 |  Source: Moneycontrol.com

Eris Lifesciences announced acquisition of nine dermatology brands from Glenmark Pharma for Rs 340 crore. The brands include Onabet, Halobate, Sorvate...

Buy Eris Lifesciences; target of Rs 850: Prabhudas Lilladher

11.34 am | 18 Jan 2023 |  Source: Moneycontrol.com

Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 850 in its research report dated...

Eris Lifesciences Q3 PAT seen up 7.2% YoY to Rs 1,080 cr: Nirmal Bang

2.10 pm | 17 Jan 2023 |  Source: Moneycontrol.com

Net Sales are expected to increase by 37 percent Y-o-Y (down 1.2 percent Q-o-Q) to Rs 4,549 crore, according to Nirmal Bang....

Buy Eris Lifesciences; target of Rs 850: Prabhudas Lilladher

2.34 pm | 25 Oct 2022 |  Source: Moneycontrol.com

Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 850 in its research report dated...

Eris Life Consolidated September 2022 Net Sales at Rs 460.51 crore, up 28.04% Y-o-Y

8.11 pm | 20 Oct 2022 |  Source: Moneycontrol.com

NULL...

Eris Life Standalone September 2022 Net Sales at Rs 355.37 crore, up 10.14% Y-o-Y

8.00 pm | 20 Oct 2022 |  Source: Moneycontrol.com

NULL...

Buy Eris Lifesciences; target of Rs 825: Prabhudas Lilladher

10.56 am | 09 Aug 2022 |  Source: Moneycontrol.com

Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 825 in its research report dated...

1 2
Quick Links for Eris Lifesciences
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.